Bouros D - Search Results

1

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.

Tzouvelekis A, Ntolios P, Karampitsakos T, Tzilas V, Anevlavis S, Bouros E, Steiropoulos P, Koulouris N, Stratakos G, Froudarakis M, Bouros D. Tzouvelekis A, et al. Among authors: bouros d, bouros e. Pulm Pharmacol Ther. 2017 Oct;46:48-53. doi: 10.1016/j.pupt.2017.08.011. Epub 2017 Aug 24. Pulm Pharmacol Ther. 2017. PMID: 28843616

2

Pneumoconiosis among Cretan dental technicians.

Froudarakis ME, Voloudaki A, Bouros D, Drakonakis G, Hatzakis K, Siafakas NM. Froudarakis ME, et al. Among authors: bouros d. Respiration. 1999;66(4):338-42. doi: 10.1159/000029404. Respiration. 1999. PMID: 10461082

3

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma.

Bouros D, Bachlitzanakis N, Kottakis J, Pfister P, Polychronopoulos V, Papadakis E, Constantopoulos S, Froudarakis M, Sichletidis L, Siafakas N. Bouros D, et al. Eur Respir J. 1999 Sep;14(3):627-32. doi: 10.1034/j.1399-3003.1999.14c24.x. Eur Respir J. 1999. PMID: 10543286 Free article. Clinical Trial.

4

Prognostic value of serum tumor markers in patients with lung cancer.

Hatzakis KD, Froudarakis ME, Bouros D, Tzanakis N, Karkavitsas N, Siafakas NM. Hatzakis KD, et al. Among authors: bouros d. Respiration. 2002;69(1):25-9. doi: 10.1159/000049366. Respiration. 2002. PMID: 11844959

5

Bronchoscopic lung volume reduction: a window for the future?

Bouros D, Froudarakis ME. Bouros D, et al. Respiration. 2004 May-Jun;71(3):214-5. doi: 10.1159/000077417. Respiration. 2004. PMID: 15133339 Free article. Review. No abstract available.

6

The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome.

Bouros D, Alexandrakis MG, Antoniou KM, Agouridakis P, Pneumatikos I, Anevlavis S, Pataka A, Patlakas G, Karkavitsas N, Kyriakou D. Bouros D, et al. BMC Pulm Med. 2004 Aug 17;4:6. doi: 10.1186/1471-2466-4-6. BMC Pulm Med. 2004. PMID: 15315713 Free PMC article.

7

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects.

Panagou P, Kottakis I, Tzouvelekis A, Anevlavis S, Bouros D. Panagou P, et al. Among authors: bouros d. BMC Pulm Med. 2004 Nov 12;4:11. doi: 10.1186/1471-2466-4-11. BMC Pulm Med. 2004. PMID: 15541173 Free PMC article.

8

Serum biomarkers in interstitial lung diseases.

Tzouvelekis A, Kouliatsis G, Anevlavis S, Bouros D. Tzouvelekis A, et al. Among authors: bouros d. Respir Res. 2005 Jul 21;6(1):78. doi: 10.1186/1465-9921-6-78. Respir Res. 2005. PMID: 16042760 Free PMC article. Review.

9

Current and future therapeutic approaches in idiopathic pulmonary fibrosis.

Bouros D, Antoniou KM. Bouros D, et al. Eur Respir J. 2005 Oct;26(4):693-702. doi: 10.1183/09031936.05.00145004. Eur Respir J. 2005. PMID: 16204603 Free article. Review.

10

Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.

Antoniou KM, Malagari K, Tzanakis N, Perisinakis K, Symvoulakis EK, Karkavitsas N, Siafakas NM, Bouros D. Antoniou KM, et al. Among authors: bouros d. BMC Pulm Med. 2006 Feb 16;6:4. doi: 10.1186/1471-2466-6-4. BMC Pulm Med. 2006. PMID: 16483363 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters